Cargando…
Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2
Niclosamide, a widely-used anthelmintic drug, inhibits SARS-CoV-2 virus entry through TMEM16F inhibition and replication through autophagy induction, but the relatively high cytotoxicity and poor oral bioavailability limited its application. We synthesized 22 niclosamide analogues of which compound...
Autores principales: | Juang, Yu-Pu, Chou, Yu-Ting, Lin, Ru-Xian, Ma, Hsiu-Hua, Chao, Tai-Ling, Jan, Jia-Tsrong, Chang, Sui-Yuan, Liang, Pi-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933873/ https://www.ncbi.nlm.nih.gov/pubmed/35344901 http://dx.doi.org/10.1016/j.ejmech.2022.114295 |
Ejemplares similares
-
Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022) -
Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2
por: Li, Rui, et al.
Publicado: (2023) -
Biological and Pharmacological Effects of Synthetic Saponins
por: Juang, Yu-Pu, et al.
Publicado: (2020) -
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
por: Jan, Jia-Tsrong, et al.
Publicado: (2021) -
Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy
por: Rejinold, N. Sanoj, et al.
Publicado: (2021)